H.B. Fuller (NYSE:FUL) Receives Consensus Rating of “Hold” from Analysts

H.B. Fuller (NYSE:FUL) has received a consensus rating of “Hold” from the five brokerages that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $75.60.

Several brokerages have commented on FUL. Vertical Research cut shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Citigroup dropped their price objective on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. Deutsche Bank Aktiengesellschaft reduced their target price on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. cut their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th.

H.B. Fuller Stock Up 1.1 %

NYSE FUL opened at $61.13 on Tuesday. The stock’s 50 day simple moving average is $66.40 and its 200 day simple moving average is $74.62. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16. H.B. Fuller has a one year low of $59.87 and a one year high of $87.67. The firm has a market cap of $3.34 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 1.17 and a beta of 1.42.

H.B. Fuller (NYSE:FUL) last issued its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The company had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The firm’s revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.32 EPS. As a group, sell-side analysts forecast that H.B. Fuller will post 4.07 earnings per share for the current fiscal year.

H.B. Fuller Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th will be issued a $0.2225 dividend. The ex-dividend date of this dividend is Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.46%. H.B. Fuller’s payout ratio is 38.53%.

Institutional Investors Weigh In On H.B. Fuller

Large investors have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp boosted its holdings in shares of H.B. Fuller by 128.8% during the fourth quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock worth $61,000 after acquiring an additional 506 shares during the period. S&CO Inc. increased its stake in shares of H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the period. Wesbanco Bank Inc. lifted its holdings in H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares during the last quarter. Geode Capital Management LLC boosted its stake in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares during the period. Finally, Amundi grew its holdings in H.B. Fuller by 191.9% in the 4th quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock valued at $1,804,000 after buying an additional 18,771 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.